diabetic foot ulcer surgery clinical examination
diabetic foot ulcer clinical examination Wagner classification

A comparative clinical photograph set illustrating the Wagner Classification System for diabetic foot ulcers across four stages (Grade 1 to Grade 4). Grade 1 (Superficial Ulcer) shows a small, localized skin lesion on the plantar surface near the base of the toes with no deep tissue involvement. Grade 2 (Deep Ulcer) depicts a larger, deeper wound penetrating to the tendon or joint capsule without abscess or osteomyelitis. Grade 3 (Osteitis/Infection) demonstrates a deep ulcer associated with significant inflammation, purulent discharge, and clinical signs of underlying bone infection or deep tissue abscess. Grade 4 (Forefoot Gangrene) shows extensive necrosis and blackening of the tissue localized to the forefoot or toes, indicating severe vascular compromise and tissue death. This series serves as an educational tool for medical professionals to differentiate between stages of diabetic foot pathology, guiding clinical management and prognosis assessment.

A series of four clinical photographs (a-d) demonstrating the progression of diabetic foot ulcers categorized by the Wagner classification system. (a) Wagner Grade 1: A superficial ulcer on the left hallux (big toe) featuring erythema, periungual inflammation, and a thickened, discolored yellowish toenail, indicative of an ischemic etiology. (b) Wagner Grade 2: A deep ulcer on the fifth digit (pinky toe) showing more extensive tissue involvement and localized cyanosis. (c) Wagner Grade 3: A neuropathic perforating ulcer extending from the plantar surface to the dorsum of the foot, associated with deep infection, abscess, and clinical signs of osteomyelitis. (d) Wagner Grade 4: Advanced diabetic foot pathology exhibiting local gangrene of the second toe and a large, deep dorsal foot ulcer. The necrotic tissue is blackened, and the wound bed is exposed, revealing underlying anatomical structures such as tendons. This set illustrates the clinical manifestations of ischemic, neuropathic, and mixed-type diabetic foot disease for educational use in wound care and endocrinology.

This composite figure presents a clinical progression timeline of a complex diabetic foot ulcer (DFU) on the left foot, categorized under the Wagner classification system. (A) Initial presentation shows a large, 6x7 cm ulcer on the plantar forefoot with surrounding maceration and a lateral abscess. (B) Following initial debridement, the wound exhibits deep tissue involvement (Wagner Grade 3), with necrotic tissue extending to the tendons and musculature of the first through third toes, accompanied by a deep 2x2x0.7 cm abscess cavity. (C) Mid-treatment status demonstrates significant clinical improvement; the wound bed appears ruddy with healthy granulation tissue, reduced exudate, and diminishing necrotic debris. (D) Final follow-up at three months shows complete secondary intention healing with full epithelialization and stable scar tissue formation. (E) An accompanying summary table provides longitudinal data on treatment phases (including Fu's subcutaneous needling), ulcer/wound dimensions, Wagner grade transition (from Grade 3 to 0), and clinical markers such as cutaneous sensation, skin temperature, and presence of pus.

Clinical photograph of a right foot demonstrating a severe, extensive Wagner Grade III or IV diabetic foot ulcer. The wound spans the lateral and dorsal aspects of the foot, extending from the distal lower leg across the ankle joint to the midfoot region. The ulcer bed is characterized by beefy red granulation tissue and deep cavitation, with visible exposure of underlying musculoskeletal structures including the ankle joint. There are focal areas of yellow/white slough and fibrin, indicative of potential infection or chronic inflammatory processes. The wound margins are irregular but well-demarcated against the surrounding hyperpigmented, intact skin. This image serves as a clinical example of complex diabetic wound progression requiring advanced surgical intervention, such as debridement and microvascular flap reconstruction. Key educational concepts include diabetic foot classification, wound bed assessment, and the management of deep tissue infections with joint involvement.
diabetic foot neuropathy ischemia monofilament test ankle brachial index

This composite educational image illustrates the Semmes-Weinstein 10 g monofilament test, a standard clinical procedure for assessing loss of protective sensation (LOPS) in patients with diabetes mellitus. The left panel demonstrates the specific testing sites marked with circles: nine sites on the plantar surface—including the distal great, third, and fifth toes; the first, third, and fifth metatarsal heads; the medial and lateral midfoot; and the heel—and one site on the dorsal surface between the first and second metatarsals. The right panel displays the clinical application of the test. A clinician’s hand is shown holding the monofilament perpendicularly to the skin of the foot's dorsal surface. The monofilament is bent into a C-shape, indicating the correct application of a 10 g buckling force. This visual serves as a procedural guide for medical professionals to screen for peripheral neuropathy and identify patients at risk for diabetic foot ulceration and secondary complications like gangrene.

A clinical photograph capturing a diabetic foot examination in a healthcare setting. The image shows a medical professional, identified as a nurse in a blue scrub suit and cap, performing a sensory assessment on an elderly male patient. The patient is lying supine on an examination table. The nurse is utilizing a specialized instrument, consistent with a Semmes-Weinstein monofilament, to test for peripheral neuropathy by applying pressure to specific points on the patient's toes and plantar surface. This procedure is a critical diagnostic step in identifying loss of protective sensation (LOPS) in patients with diabetes mellitus, aimed at preventing ulcers and complications related to diabetic foot disease. The setting includes clinical furniture, patterned linens, and privacy curtains, illustrating a standard outpatient diabetic screening environment.

Clinical photograph of a sensory assessment being performed on a human foot using a 5.07 Semmes-Weinstein 10 g monofilament. The image shows a clinician's hand holding a white plastic monofilament device, applying the thin black filament to the dorsal surface of the distal hallux (big toe). The filament is buckled into a characteristic 'C' shape, indicating that exactly 10 g of pressure is being applied to test for Loss of Protective Sensation (LOPS). The foot exhibits several clinical signs associated with diabetic peripheral neuropathy, including skin dryness, hyperpigmentation, and a scaly, hyperkeratotic lesion near the lateral malleolus. The toenails appear thickened and dystrophic. This procedure is a critical screening tool for identifying patients at high risk for diabetic foot ulceration and neuropathic complications.
Campbell's Operative Orthopaedics 15th Ed 2026 - Ch. 91

1.3 = non-compressible vessels (medial calcinosis - falsely elevated)
| Grade | Description |
|---|---|
| 0 | No ulcer; pre-ulcerative or healed lesion |
| 1 | Superficial ulcer - skin depth only, no bone/tendon/joint |
| 2 | Deep ulcer penetrating to tendon, bone, or joint capsule |
| 3 | Deep ulcer with osteomyelitis, abscess, or joint sepsis |
| 4 | Localized gangrene - forefoot/toes |
| 5 | Extensive gangrene - whole foot |

Current Surgical Therapy 14e - Wound grading section
| Investigation | Purpose |
|---|---|
| X-ray foot (3 views) | Osteomyelitis (cortical destruction), Charcot changes, prior amputations, heterotopic ossification, gas in tissues |
| ESR, CRP, WBC | Infection/osteomyelitis screening |
| HbA1c | Glycaemic control - elevated HbA1c increases risk of surgical failure |
| MRI foot | Gold standard for osteomyelitis; soft tissue extent |
| Bone scan / WBC scan | If MRI unavailable |
| Bone biopsy | Histology + culture for definitive osteomyelitis diagnosis (recommended by guidelines) |
| Vascular duplex / CTA / MRA | If revascularization being considered |
| ABI / TBI | Bedside vascular screening |
| Deep wound swab / tissue culture | Guide antibiotic therapy (surface swabs unreliable) |
| Nutritional markers | Albumin, pre-albumin, transferrin (critical before amputation) |
what are the examination that can be done

| ABI Value | Interpretation |
|---|---|
| 0.9 - 1.2 | Normal |
| 0.7 - 0.9 | Mild PAD |
| 0.5 - 0.7 | Moderate PAD |
| < 0.5 | Severe - unlikely to heal without revascularization |
| > 1.3 | Non-compressible (calcified) - result invalid |
3 seconds = impaired perfusion
| Test | What It Detects |
|---|---|
| Handheld Doppler | Audible waveform quality (triphasic = normal, biphasic = mild PAD, monophasic = severe PAD) |
| Transcutaneous Oxygen (TcPO2) | Tissue oxygen delivery; >30 mmHg needed for healing |
| Skin Perfusion Pressure | Alternative to TBI in calcified vessels |
| Wagner Classification | Grades ulcer 0-5 for surgical planning |
| WIFI Score | Wound + Ischemia + Foot Infection → predicts 1-year amputation risk |
1. INSPECT both feet without socks
2. Neurological: monofilament → vibration → pinprick → temperature → reflexes
3. Vascular: pulses → ABI → TBI (if ABI invalid) → Buerger's test
4. Wound: debride callus → measure → probe-to-bone → grade (Wagner)
5. Musculoskeletal: deformities → Achilles tightness → gait
6. Systemic: vitals → lymph nodes → eyes → nutrition
Sources: Campbell's Operative Orthopaedics 15th Ed 2026; Current Surgical Therapy 14e; Fischer's Mastery of Surgery 8th Ed; Bailey and Love's 28th Ed
diabetic foot ulcer surgery notes
diabetic foot surgery debridement amputation transmetatarsal surgical technique

Clinical photographs of a diabetic foot with a large, complex surgical wound following excisional debridement and transmetatarsal amputation. The images show a deep, irregular wound bed spanning the dorsal and medial aspects of the foot. The tissue composition is heterogeneous, featuring areas of beefy red granulation tissue interspersed with patches of yellowish slough and fibrin. Some deep structures, potentially including exposed bone or fascia, are visible. The wound margins are irregular, exhibiting erythema and edema indicative of localized inflammation. Areas of clotted blood and dark, devitalized tissue are present, reflecting the immediate post-debridement state before Vacuum-Assisted Closure (VAC) therapy. The periwound skin shows signs of chronic peripheral arterial disease and venous insufficiency, including discoloration, pallor, and mottled skin distal to the ankle, suggesting compromised regional circulation. This visual illustrates the surgical management of critical limb ischemia and diabetic foot ulcers in an educational context.

Two-panel clinical photograph demonstrating progressive infectious necrosis and subsequent surgical management in a diabetic patient. Panel A shows a dorsal view of a right foot featuring a grade 3, stage D lesion localized to the hallux (big toe). The area displays extensive tissue necrosis, dark eschar, and surgical sutures indicating a prior intervention. Multiple fluid-filled bullae and purplish-gray ecchymotic patches are visible on the dorsal midfoot, suggesting spreading infection. Panel B displays the same limb following a transmetatarsal or forefoot amputation. The surgical stump is closed with primary sutures, though the incision line appears dark and potentially necrotic. The remaining skin of the foot is pale. A gloved hand is shown stabilizing the amputated limb against a clinical background. These images illustrate the rapid progression of a fungal infection (Sarocladium spp.) requiring escalating surgical debridement and amputation in an immunocompromised, diabetic host.

A longitudinal series of eight clinical photographs (A–H) documenting the management and healing progression of a diabetic foot ulcer following various levels of amputation. Image (A) shows initial hallux and first ray necrosis with infection. Subsequent images (B–C) depict the surgical site following transmetatarsal and Lisfranc amputations, characterized by deep, irregular wound beds with fibrin, slough, and dark necrotic tissue. Images (D–E) illustrate the transition to a healthy, beefy-red granulation tissue bed following wound environment control and debridement. Image (F) shows the prepared wound bed prior to skin grafting, with a metric ruler for scale. Final images (G–H) track the outcome of the skin graft over three months, demonstrating progressive contraction and complete epithelialization. The series highlights clinical markers of healing, including the reduction of necrotic slough, the emergence of vascularized granulation tissue, and the final transition to mature, pigmented skin coverage.

Clinical photograph showing three views (dorsal, plantar, and medial/lateral) of a left foot 18 months after percutaneous Deep Vein Arterialization (pDVA) for chronic limb-threatening ischemia (CLTI). The foot demonstrates successful salvage and complete epithelialization following a transmetatarsal amputation and previous toe debridement. Visually, the skin across all views exhibits a healthy, pinkish-red hue indicative of adequate distal perfusion. The plantar view shows smooth, intact skin without active ulceration. The dorsal and side views reveal a well-healed, linear surgical scar at the amputation site with well-approximated edges and no signs of inflammation, infection, or necrotic tissue. The educational focus of the image is to demonstrate the long-term clinical outcome and wound healing success of pDVA in a diabetic patient with severe calcific occlusive disease, showing the preservation of the foot and resolution of ischemic rest pain.
NEUROPATHY
|
ISCHAEMIA + INFECTION = TISSUE LOSS → AMPUTATION
|
BIOMECHANICAL PRESSURE
| Test | Significance |
|---|---|
| HbA1c | >7% = higher complication risk; >pre-op glucose >200 mg/dL = increased nonunion, infection, wound failure |
| FBC, ESR, CRP | Infection/osteomyelitis baseline |
| Renal function | Affects drug dosing, wound healing |
| ABI / TBI | Determines vascular adequacy for healing (ABI <0.5 = revascularize first) |
| Doppler duplex / CTA / MRA | If revascularization planned |
| X-ray foot (3 views) | Osteomyelitis, Charcot changes, gas in soft tissue, structural deformity |
| MRI foot | Gold standard for osteomyelitis extent; soft tissue planes |
| Bone scan / WBC scan | If MRI contraindicated (metal implants, pacemaker) |
| Deep tissue / bone culture | Before antibiotics; surface swabs are unreliable |
| Nutritional markers | Albumin, pre-albumin, transferrin |
| Domain | Grade 0 | Grade 1 | Grade 2 | Grade 3 |
|---|---|---|---|---|
| Wound | No ulcer/pre-ulcer | Shallow, no bone | Exposed bone/tendon, heel ulcer | Extensive ulcer/gangrene |
| Ischaemia | Toe pressure ≥60 mmHg | Mild | Moderate | Severe |
| Foot Infection | None | Local <2 cm | >2 cm / abscess / osteomyelitis | SIRS |
SURGICAL LADDER (Limb-Sparing → Amputation)
├── Debridement (sharp, surgical)
├── Abscess drainage
├── Revascularization (endovascular / bypass)
├── Osteomyelitis resection
├── Structural correction (Achilles lengthening, metatarsal head resection)
├── Toe amputation
├── Ray amputation (1st / 5th / central / multiple)
├── Transmetatarsal amputation (TMA)
├── Lisfranc / Chopart amputation
├── Syme amputation
├── Below-knee amputation (BKA)
└── Above-knee amputation (AKA)
| Type | Description |
|---|---|
| Sharp/surgical | Scalpel/curette; first-line; removes all necrotic/infected tissue |
| Mechanical | Wet-to-dry dressings (less specific; painful) |
| Autolytic | Moisture-retentive dressings (slow, for non-infected wounds) |
| Enzymatic | Collagenase (Santyl), MediHoney - for fibrinous tissue |
| Negative Pressure (VAC) | Vacuum-Assisted Closure - see below |
| Method | Details |
|---|---|
| Endovascular (PVI) | First-line; angioplasty ± stenting; lower perioperative risk; lower 4-year patency than bypass |
| Open surgical bypass | Single-segment saphenous vein graft preferred; translocated (not reversed) fashion for tibial size-match; arm vein if no saphenous |
| Hyperbaric oxygen | Last resort when revascularization not possible; indications: osteomyelitis, gangrene, open wound with inadequate perfusion |

| Closure Type | Indication |
|---|---|
| Primary closure | Clean, tension-free wound |
| Delayed primary closure | Infected wound - close at 48-96 hours after open inspection |
| Secondary intention | Compromised vascularity, incomplete debridement |
| Negative pressure (VAC) | Open wounds; bridge to closure |
| Integra dermal template | Exposed tendon or bone; insufficient skin for grafting |
| Split-thickness skin graft (STSG) | After 3-4 weeks on Integra (when silicone layer removed) |
| Local flaps | Advancement, rotation, transposition, pedicle flaps for limited coverage |
| Free flap (vascularized) | Extensive coverage needs; consult plastics early |
| Procedure | Purpose |
|---|---|
| Achilles tendon lengthening | Reduces forefoot/midfoot pressure; essential with TMA; threshold low for midfoot/forefoot ulcers |
| Metatarsal head resection | Corrects deformity; reduces recurrence; transfers pressure points |
| Gastrocnemius recession | Alternative to Achilles lengthening for equinus deformity |
| Lapidus procedure | After 2nd ray resection to prevent valgus deformity |
| Exostectomy | Remove bony prominences (Charcot foot) causing pressure |
| Charcot stabilization | Internal/external fixation for unstable rocker-bottom deformity |
| Liquid silicone injection | Plantar pressure reduction (adjunct) |
| Complication | Notes |
|---|---|
| Wound dehiscence / failure | Most common; higher risk with HbA1c >7%, glucose >200, malnutrition |
| Proximal amputation revision | 30% of initial amputations progress to higher level |
| Osteomyelitis recurrence | Residual infection leads to further amputation |
| Plantarflexion contracture | After TMA if Achilles not lengthened |
| Transfer ulceration | After ray resection; pressure transfers to adjacent areas |
| Phantom limb pain | After amputation |
| Haematoma | Avoid tourniquet use; meticulous haemostasis |
| Skin edge necrosis | Avoid forceps pressure on skin; use thick flaps |
| Stump infection | Common in diabetics; culture-guided antibiotics |
| Specialist | Role |
|---|---|
| Vascular surgeon | Revascularization, amputation level |
| Orthopaedic / Podiatric surgeon | Debridement, amputations, deformity correction |
| Plastic surgeon | Flap coverage, skin grafting |
| Endocrinologist | Glycaemic optimization |
| Infectious disease | Antibiotic selection, osteomyelitis management |
| Nutritionist / Dietitian | Nutritional supplementation pre/post-op |
| Orthotist / Prosthetist | Offloading, footwear, post-amputation prosthetics |
| Wound care nurse | Dressing management, monitoring |
- Never aggressively debride without adequate perfusion - unless severe, life-threatening infection is present
- Revascularize before elective surgery if ABI <0.5 or toe pressure <40 mmHg
- Achilles tendon lengthening with any TMA - almost always required
- Preserve plantar skin - it cannot be replaced; key for all forefoot amputations
- Leave infected wounds open - staged closure at 48-96 hours
- Avoid tourniquet in ischaemic limbs
- Avoid thin flaps in diabetics - especially with osteomyelitis; take incision to bone
- Thick flaps, no forceps pressure on skin edges
- Culture before antibiotics - culture at time of debridement, not empirically from surface swab
- Glycaemic control is non-negotiable - glucose >200 mg/dL pre-op markedly increases complications